Welcome to BiotechBlog. I am Yali Friedman and I publish on the business of biotechnology. Subscribe via RSS feed or email to receive site updates!

Biotech U — Free online biotechnology course

July 7, 2010

I’ve decided to open up Biotech U and make the comprehensive biotechnology industry overview course free for the month of July. The course is derived from my textbook, Building Biotechnology, and covers the following topics: Biotechnology Industry Introduction The Development of Biotechnology Preface: The Science of Biotechnology Introduction to Molecular Biology Drug Development Tools and [...]

Read the full article →

Drug Patent Expirations in July 2010

July 1, 2010

Drug Patent Expirations in July 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration PROAIR HFA Teva Global albuterol sulfate 5,695,743 Jul 6, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,225,183 Jul 6, 2010 PROVENTIL-HFA 3m albuterol sulfate 5,439,670 Jul 6, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,695,743 Jul [...]

Read the full article →

Biosimilar drugs to gain greater priority as decade progresses

June 21, 2010

This is a guest post from Keith Bradbury, Executive Director of Drug Information at Medco Health Solutions, Inc. Biosimilar drugs to gain greater priority as decade progresses The Patient Protection and Affordable Care Act will heighten the degree of competition in the field of biotech drugs, a fast growing area of drug therapy that is [...]

Read the full article →

Biotechnology Management Papers, 2010

June 17, 2010

These papers are from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: If You Build It, Will They Come? Derek Francis Profitability [...]

Read the full article →

Profitability and Orphans: The Role of Price and Incentives in Four Different Markets

June 16, 2010

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Profitability and Orphans: The Role of Price [...]

Read the full article →

If You Build It, Will They Come?

June 15, 2010

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. If You Build It, Will They Come? [...]

Read the full article →

Patent Analysis: A Tool for Making Strategic Business Decisions

June 14, 2010

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Patent Analysis: A Tool for Making Strategic [...]

Read the full article →

Drug Patent Expirations in June 2010

June 2, 2010

Drug Patent Expirations in June 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration NICOTROL Mcneil Cons nicotine 6,098,632 Jun 8, 2010 NICOTROL Pharmacia And Upjohn nicotine 5,400,808 Jun 8, 2010 NICOTROL Pharmacia And Upjohn nicotine 6,098,632 Jun 8, 2010 NICOTROL Mcneil Cons nicotine 5,501,236 Jun 8, 2010 [...]

Read the full article →

Coming soon: Building the case for biotechnology

June 1, 2010

Announcing a new textbook from Logos Press: Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business Mark J. Ahn, Michael A. Alvarez, Arlen D. Meyers, Anne S. York, editors Foreword by G. Steven Burrill First Edition, July 2010 Perfect Bound, 416 pages, US$79.95 ISBN: 978-1-934899-15-1 This volume helps to [...]

Read the full article →

Guest post: Healthcare Reform Bill Presents Significant Opportunity for Life Science Companies Engaged in Innovative Research

May 17, 2010

This is a guest post from William H. Kitchens, partner at the Atlanta law firm Arnall Golden Gregory LLP. Do you have a response to Kitchens’ post? Respond in the comments section below. Buried in the recently enacted Patient Protection and Affordable Care Act of 2010 is a significant benefit for small- and mid-sized biotech, [...]

Read the full article →

← Previous Entries

Next Entries →